Showing results (121-130 of 156) with videos related to
Sort By:
Pageof 16
Journal of Hepatology|July 15, 2020
Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitisMarta Vuerich, Rasika Harshe, Luiza Abrahão Frank, et al.Journal of Autoimmunity|December 24, 2023
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitisLi Gao, Wei Zhang, Lina Zhang, et al.Journal of Clinical Medicine|October 29, 2025
Outcomes of Living-Donor Liver Transplantation for Cholangiocarcinoma Versus Hepatocellular Carcinoma in the United StatesMerve Gurakar, Ozge Sila Ozgur, Ayse Eylul Donmez, et al.The American Journal of Gastroenterology|July 8, 2015
Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US populationNatalia E Castillo, Rohini R Vanga, Thimmaiah G Theethira, et al.Gastrointestinal Endoscopy|December 16, 2021
EUS imaging for the diagnosis of nonalcoholic fatty liver diseaseAndy Silva-Santisteban, Abhishek Agnihotri, Cinthia Cruz-Romero, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 28, 2026
Redefining liver transplant priority: Waitlist outcomes for HCC after MMaT-3 donor hospital-based allocation reformEsli Medina-Morales, Yash Shah, Anastasia Xynogala, et al.Lancet (London, England)|March 19, 2013
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trialKris V Kowdley, Eric Lawitz, Israel Crespo, et al.Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysisK Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.Hepatology (Baltimore, Md.)|August 1, 2021
A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH CirrhosisJaime Bosch, Chuhan Chung, Oscar M Carrasco-Zevallos, et al.Journal of Autoimmunity|July 20, 2026
Immunomodulatory effects of tacrolimus-loaded lipid-core nanocapsules in autoimmune hepatitisGraziela S Gomes, Cortney Cagle, William Li, et al.Pageof 16